Structure Therapeutics Inc. American Depositary Shares vs. Eli Lilly & Co.
GPCR
Structure Therapeutics Inc. American Depositary Shares
$40.38 -14.70%
VS LLYEli Lilly & Co.
$1125.85 +0.17%
Eli Lilly & Co. (LLY) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| GPCR | LLY | |
|---|---|---|
| Market Cap | $2.88 billion | $1.00 trillion |
| Revenue (TTM) | — | $79.67 billion |
| Net Income (TTM) | $-214,835,000 | $26.71 billion |
LLY leads on 3 of 3 size & scale factors.
Valuation
| GPCR | LLY | |
|---|---|---|
| P/E Ratio | — | 37.79 |
| Price / Book | 2.13 | 29.57 |
| Price / Sales | — | 12.58 |
GPCR leads on 1 of 1 valuation factors.
Profitability
| GPCR | LLY | |
|---|---|---|
| Net Margin | — | 33.53% |
| Return on Equity | -15.86% | 78.84% |
LLY leads on 1 of 1 profitability factors.
Dividend
| GPCR | LLY | |
|---|---|---|
| Dividend Yield | — | 0.61% |
| Payout Ratio | — | 23.23 |
GPCR and LLY split the dividend factors evenly.
Risk & Sentiment
| GPCR | LLY | |
|---|---|---|
| Short Interest | 0.02% | 1.29% |
GPCR leads on 1 of 1 risk & sentiment factors.
Dig deeper: GPCR overview, GPCR financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
